Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Bought by Cambridge Financial Group Inc.

Cambridge Financial Group Inc. grew its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.6% during the first quarter, HoldingsChannel reports. The firm owned 99,867 shares of the pharmacy operator’s stock after buying an additional 7,070 shares during the period. Walgreens Boots Alliance accounts for 3.1% of Cambridge Financial Group Inc.’s portfolio, making the stock its 23rd largest position. Cambridge Financial Group Inc.’s holdings in Walgreens Boots Alliance were worth $4,569,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Walgreens Boots Alliance by 1.8% during the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,484,065 shares of the pharmacy operator’s stock worth $853,980,000 after purchasing an additional 257,400 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Walgreens Boots Alliance by 1.9% during the fourth quarter. Geode Capital Management LLC now owns 11,207,142 shares of the pharmacy operator’s stock worth $659,354,000 after acquiring an additional 205,271 shares during the last quarter. Norges Bank purchased a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth about $492,928,000. American International Group Inc. increased its position in shares of Walgreens Boots Alliance by 781.9% during the fourth quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock worth $324,980,000 after acquiring an additional 4,886,896 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Walgreens Boots Alliance by 3.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,959,827 shares of the pharmacy operator’s stock worth $233,472,000 after acquiring an additional 134,674 shares during the last quarter. Institutional investors own 58.03% of the company’s stock.

WBA stock traded down $0.15 during midday trading on Friday, reaching $39.60. The company had a trading volume of 3,378,765 shares, compared to its average volume of 7,383,946. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 1.34. The stock has a 50 day moving average price of $42.22 and a 200 day moving average price of $51.33. Walgreens Boots Alliance Inc has a fifty-two week low of $36.65 and a fifty-two week high of $64.50. The firm has a market capitalization of $34.87 billion, a PE ratio of 6.87, a P/E/G ratio of 1.83 and a beta of 0.55.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 EPS for the quarter, beating the Zacks’ consensus estimate of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company had revenue of $35.82 billion during the quarter, compared to the consensus estimate of $35.24 billion. During the same period in the previous year, the firm posted $1.64 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 3.7% compared to the same quarter last year. Research analysts predict that Walgreens Boots Alliance Inc will post 5.53 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Wednesday, May 20th will be paid a $0.4575 dividend. The ex-dividend date of this dividend is Tuesday, May 19th. This represents a $1.83 dividend on an annualized basis and a yield of 4.62%. Walgreens Boots Alliance’s payout ratio is currently 30.55%.

A number of analysts have recently issued reports on the company. Barclays dropped their target price on Walgreens Boots Alliance from $60.00 to $50.00 and set an “equal weight” rating on the stock in a research report on Friday, April 3rd. Credit Suisse Group dropped their target price on Walgreens Boots Alliance from $60.00 to $50.00 and set a “neutral” rating on the stock in a research report on Friday, April 3rd. JPMorgan Chase & Co. dropped their target price on Walgreens Boots Alliance from $62.00 to $56.00 and set a “neutral” rating on the stock in a research report on Friday, April 3rd. TheStreet lowered Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research report on Tuesday, February 25th. Finally, SunTrust Banks dropped their target price on Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating on the stock in a research report on Friday, April 3rd. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $51.21.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: What are the reasons investors use put options?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.